Microfluidics Market Size Worth USD 104.17 Billion in 2032 | Emergen Research

Emergen ResearchEmergen Research
Emergen Research

Rapid technological advancements in the field of microfluidics and Point-of-Care testing and IVD is a key factor driving microfluidics market revenue growth

Vncouver, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The global microfluidics market size reached USD 104.17 Billion in 2032 and is expected to register a revenue CAGR of 16.1% during the forecast period, according to latest analysis by Emergen Research. Rapid technological advancements in the field of microfluidics such as Point-of-Care Testing (PoCT) and In-Vitro Diagnostics (IVD), significant investments in research & development activities, rising demand for microfluidic platforms for early disease detection and pathogen identification, as well as increasing applications of microfluidic platforms in various healthcare industries are factors driving market revenue growth.

Microfluidic devices used for diagnostic purposes offer rapid detection, convenience of use, cost-effectiveness, and high precision in identifying infectious diseases, including HIV, HBV, and ZIKV. Use of microfluidic chips in medicine reduces time between identification and initiation of therapeutic treatment, which is critical for patient survival. Portable microfluidic kits can be especially beneficial in areas where healthcare facilities and services are poor. Sustained development of new microfluidics technologies such as 3-D printed wearable microfluidic devices, point-of-care/Lab-On-Chip (LOC) devices, and organ-on-chip devices is expected to result in deployment of innovative strategies for future microfluidic devices, which will be more readily available and accessible. This will result in less expensive, more integrated, and even more customizable chips made from various novel materials with higher precision and reliability.

Microfluidics-based POC devices such as wearable devices with Wi-Fi capabilities have potential to improve healthcare by enabling easier monitoring, early disease diagnosis, and better customization. Wearable adaptable sensors based on integrated microfluidic systems with multiplex analytic capacity are gaining traction, as a new way of assessing human health status, with applications in clinical care and athletic monitoring. Microfluidic sensors that are well-designed can be applied to skin surface to obtain numerous bits of physiological data such as sweat loss, metabolite information, and electrolyte balance with high accuracy.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/35

On 4 October 2021 for instance, Epicore Biosystems, which is a provider of digital health solutions, launched its Discovery Patch Sweat Collection System (Discovery Patch System). This platform comprises a wearable microfluidic patch that collects sweat directly from the skin during exercise, environmental exposure, or pharmacologic sweat induction, and this microfluidic patch is meant to rapidly collect and prepare sweat samples for biochemical analysis. Furthermore, significant investments in R&D activities for microfluidics in various healthcare sectors such as drug delivery systems and pharmaceutical & biotechnology research are driving microfluidic market revenue growth.

However, lack of trained workers or medical professionals and challenges related to mass production are key factors hampering revenue growth of the market. A number of LOC microfluidic systems require complex and labor-intensive manufacturing procedures to produce individual components and overall product. Majority of end-use facilities are unwilling to modify their traditional methods and equipment since additional training could be required to operate devices. As a result of these roadblocks, preference to use traditional instruments is relatively high in some countries. This difficulty lowers marketing strategy for microfluidic devices and reduces motivation to utilize these units in a lab or frontline.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/35

Scope of Research

Report Details

Outcome

Market Size in 2021

USD 20.14 Billion

CAGR (2023–2032)

16.1%

Revenue Forecast to 2032

USD 104.17 Billion

Base Year for Estimation

2022

Historical Data

2019–2021

Forecast Period

2023–2032

Quantitative Units

Revenue in USD Billion and CAGR in % from 2023 to 2032

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

Material type, application, components, and region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country Scope

U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa

Key Companies Profiled

UFluidix, Quidel Corporation, biosurfit SA, Abbott, Illumina, Inc., Abaxis, PerkinElmer Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and Becton Dickinson and Company (BD)

Customization Scope

10 hours of free customization and expert consultation

Major Companies and Competitive Landscape

The global microfluidics market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective biocomposite solutions. Some major companies included in the global microfluidics market report are:

  • UFluidix

  • Quidel Corporation

  • biosurfit SA

  • Abbott.

  • Illumina, Inc.

  • Abaxis,

  • PerkinElmer Inc.

  • Bio-Rad Laboratories, Inc.

  • F. Hoffmann-La Roche Ltd.

  • Becton Dickinson and Company (BD)

Strategic Development

  • On 10 May 2022, Xidas, which is a startup that provides the world's most integrated microfluidics solutions, started shipping review prototypes of its smart, microfluidic in-line pressure sensor with near-zero dead volume. The ‘Pascal’ family of sensors from Xidas is designed for in-line monitoring of ultra-small amounts of fluid. These are low voltage and totally digital, have on-board computation, and allow genuine in-line fluid sensing with less than 0.1 microliters of dead volume. Xidas’ small volume sensors are used in wearable medication delivery devices, portable diagnostics devices, in-line process monitors, microcatheters, and high throughput biological systems.

  • On 24 March 2022, Miroculus announced to launch Miro Canvas, which is a compact and easy-to-use digital microfluidics platform to automate complex Next-Generation Sequencing (NGS) sample preparation protocols.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/35

Some Key Highlights from the Report

  • The polymer segment accounted for a significantly robust revenue share in 2021. Increasing demand from the packaging industry due to low cost and well-maintained fabrication techniques, for which polymers are favored is a key factor driving revenue growth of this segment. Poly(dimethylsiloxane) (PDMS) is a preferred choice from among these materials and has been widely used in microfluidics for fast and quick prototyping reasons, as it is easy to make and adheres tightly to glass and PDMS substrates with greater and improved optical transparency and elastomeric characteristics. Two perfluorinated polymers are utilized to construct microfluidic devices and structures, perfluoroalkoxy (Teflon PFA) and fluorinated ethylenepropylene (Teflon FEP), as these maintain their elastomeric and inertness, which makes them suitable for microfluidic platforms.

  • The microfluidic chip segment accounted for a significantly large revenue share in 2021. Microfluidic chips ae based on miniaturization technology to enable entire biochemical processes including reagent loading, reaction, separation, and detection, to be performed on a microchip. Densely interconnected microfluidic chips are small, portable, and only require a few consumables for early disease detection. Microfluidic technologies such as LOC technology, Three-Dimensional (3D) cell culture, organs-on-a-chip, and droplet techniques have advanced rapidly into various fields. Microfluidic chips, in combination with various detection techniques, are ideal for high-throughput drug testing, detection, and mechanistic research. These chips can be utilized in nanoparticle synthesis, drug encapsulation, delivery, targeting, cell analysis, and cell culture, either alone or in combination with other devices.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/microfluidics-market

Emergen Research has segmented the global microfluidics market based on material type, application, component, and region:

  • Material Type Outlook (Revenue, USD Billion; 2019-2032)

    • Polymer

    • Silicone

    • Glass

    • Others

  • Application Outlook (Revenue, USD Billion; 2019-2032)

    • Point-of-Care Testing (POCT) Diagnostics

    • Drug Delivery Systems

    • Pharmaceutical and Biotechnology Research

    • Clinical Diagnostics

    • Others

  • Components Outlook (Revenue, USD Billion; 2019-2032)

    • Microfluidic Chips

    • Micropumps

    • Microneedles

    • Others

  • Regional Outlook (Revenue, USD Billion; 2019–2032)

    • North America

      1. U.S.

      2. Canada

      3. Mexico

    • Europe

      1. Germany

      2. France

      3. UK

      4. Italy

      5. Spain

      6. Benelux

      7. Rest of Europe

    • Asia Pacific

      1. China

      2. India

      3. Japan

      4. South Korea

      5. Rest of APAC

    • Latin America

      1. Brazil

      2. Rest of LATAM

    • Middle East & Africa

      1. Saudi Arabia

      2. UAE

      3. South Africa

      4. Turkey

      5. Rest of Middle East & Africa

Curated Reports You Shouldn't Miss: Dive In Now!

Bariatric Surgery Market Size, Share, Trends, By Device (Implantable Devices, Assisting Devices), By Surgery (Invasive Surgery, Non-Invasive Surgery), By Procedure (Gastric Sleeve Surgery, Adjustable Gastric Band, Gastric Bypass), By End-use, and By Region, Forecast to 2028

Minimally Invasive Surgical Systems Market, By Device Type (Handheld Devices, Cutter Devices, Inflation Devices, Electrosurgical Devices, Monitoring, and Visual Device), By Surgery Type, By End-Use, and By Region Forecast to 2030

Dental 3D Printing Market By Component (Materials, Equipment, Services), By Technology (Selective Laser Sintering, Vat Photopolymerization, PolyJet Printing, Fused Deposition Modelling), By Application (Orthodontics, Prosthodontics, Implantology), By End-Use (Hospitals & Clinics, Laboratories, Research Institutes), and By Region Forecast to 2028

Autoinjectors Market By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, and Others), By Type (Disposable and Reusable), By Route of Administration, By End-Use, and By Region Forecast to 2030

Blood Collection Market, Product Type (Blood Collection tubes and Needles & Syringes), By Technology (Manual Blood Collection and Automated Blood Collection), By Method, By Application, By End User, and By Region Forecast to 2030

Face Mask Market By Product Type (Surgical Masks, Respirators), By Material Type (Polyurethane, Polypropylene, Polyester, Cotton), By Usability (Disposable, Reusable), By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Research Institutes, Industries, Individuals), and By Region Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Microfluidics Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-microfluidics-market


Advertisement